JP2025501509A5 - - Google Patents
Info
- Publication number
- JP2025501509A5 JP2025501509A5 JP2024535921A JP2024535921A JP2025501509A5 JP 2025501509 A5 JP2025501509 A5 JP 2025501509A5 JP 2024535921 A JP2024535921 A JP 2024535921A JP 2024535921 A JP2024535921 A JP 2024535921A JP 2025501509 A5 JP2025501509 A5 JP 2025501509A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- halo
- cycloalkyl
- heterocycline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163289830P | 2021-12-15 | 2021-12-15 | |
| US63/289,830 | 2021-12-15 | ||
| PCT/US2022/081519 WO2023114822A1 (en) | 2021-12-15 | 2022-12-14 | Benzothiazole, benzoisoxazole and benzodioxole analogs as rxfp1 receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501509A JP2025501509A (ja) | 2025-01-22 |
| JP2025501509A5 true JP2025501509A5 (enExample) | 2025-12-18 |
Family
ID=85278236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535921A Pending JP2025501509A (ja) | 2021-12-15 | 2022-12-14 | Ｒｘｆｐ１受容体アゴニストとしてのベンゾチアゾール、ベンゾイソオキサゾールおよびベンゾジオキソールアナログ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250066344A1 (enExample) |
| EP (1) | EP4448500A1 (enExample) |
| JP (1) | JP2025501509A (enExample) |
| KR (1) | KR20240120745A (enExample) |
| CN (1) | CN118401502A (enExample) |
| WO (1) | WO2023114822A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106780A1 (en) * | 2023-11-17 | 2025-05-22 | Eli Lilly And Company | Rxfp1 receptor agonists |
| WO2025235833A1 (en) * | 2024-05-10 | 2025-11-13 | Eli Lilly And Company | Rxfp1 receptor agonists |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2929283T3 (es) * | 2012-05-04 | 2022-11-28 | Us Health | Moduladores del receptor de relaxina 1 |
| CN106316987B (zh) * | 2015-07-03 | 2020-11-17 | 江苏恒瑞医药股份有限公司 | 苯甲酰胺类衍生物、其制备方法及其在医药上的应用 |
| WO2019057969A1 (en) * | 2017-09-22 | 2019-03-28 | Johann Wolfgang Goethe-Universität | DOUBLE AGONISTS OF FXR AND PPARδ, AND USES THEREOF |
-
2022
- 2022-12-14 JP JP2024535921A patent/JP2025501509A/ja active Pending
- 2022-12-14 WO PCT/US2022/081519 patent/WO2023114822A1/en not_active Ceased
- 2022-12-14 CN CN202280082604.8A patent/CN118401502A/zh active Pending
- 2022-12-14 EP EP22859491.7A patent/EP4448500A1/en active Pending
- 2022-12-14 US US18/718,477 patent/US20250066344A1/en active Pending
- 2022-12-14 KR KR1020247023154A patent/KR20240120745A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540164A5 (enExample) | ||
| JP2024543013A5 (enExample) | ||
| JP2024540163A5 (enExample) | ||
| JP2009523841A (ja) | 一酸化炭素の治療的供給 | |
| JP2024504932A5 (enExample) | ||
| US9108902B2 (en) | Deuterated 2-amino-3-hydroxypropanoic acid derivatives | |
| RU94041739A (ru) | Производные сульфонамида, фармацевтическая композиция и способы лечения и профилактики заболеваний. новые сульфонамидные антагонисты рецептора фибриногена | |
| JP2021514001A5 (enExample) | ||
| RU2004109812A (ru) | Ингибиторы цистеинпротеазы 2-циано-4-аминопиримидинового строения с ингибирующим действием на катепсин к для лечения воспалительных и других заболеваний | |
| RU2009135389A (ru) | Четвертичные аммониевые дифенилметилсоединения, применимые в качестве антагонистов мускариновых рецепторов | |
| JP2021534108A5 (enExample) | ||
| JP2022522486A5 (enExample) | ||
| JP2012522759A5 (enExample) | ||
| KR900016197A (ko) | 혈전증 및 혈관경련 질환의 치료에 유용한 인터페닐렌 7-옥사비시클로헵틸 치환 헤테로시클릭 아미드 프로스타글란딘 유사체 | |
| BG65135B1 (bg) | Производни на изосорбид мононитрат и тяхното използване като вазодилатиращо средство с намалена толерантност | |
| JP2024546943A5 (enExample) | ||
| JP2024546946A5 (enExample) | ||
| JP2022537350A5 (enExample) | ||
| JP2024540161A5 (enExample) | ||
| JP2024546944A5 (enExample) | ||
| JP4076441B2 (ja) | 新規脂肪族化合物、その製造方法、及びその利用方法 | |
| JP2025503442A5 (enExample) | ||
| RU2004102513A (ru) | Новое соединение для лечения импотенции | |
| JP2007509052A5 (enExample) | ||
| US20090175824A1 (en) | Peptides for the treatment of HCV infections |